- Supported exchanges /
- PINK /
- RASP.PINK
Rasna Therapeutics Inc (RASP PINK) stock market data APIs
Actavia Life Sciences, Inc., a leukemia-focused biotechnology company, engages in developing therapeutics for the treatment of acute myeloid leukemia (AML) and other forms of leukemia and lymphoma. It is developing RASP-201, a novel, orally dosed, selective reversible inhibitor of lysine specific demethylase, a pathway that blocks differentiation and confers a poor prognosis to AML; and RASP-301, an NCE for NPM1, currently at the pre-clinical stage to treat refractory AML with reduced toxicity. The company was formerly known as Rasna Therapeutics, Inc. and changed its name to Actavia Life Sciences, Inc. in October 2023. Actavia Life Sciences, Inc. was founded in 2013 and is headquartered in New York, New York.
Rasna Therapeutics Inc Financial Data Overview
0.004 | |
0.004 | |
- | |
0.004 | |
0.004 | |
0.0016-0.039 | |
3 087 K | |
0 | |
772 M | |
0 | |
-0.0001 | |
-64.361 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Rasna Therapeutics Inc Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA -383 598
- Earnings Per Share 0
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Rasna Therapeutics Inc Earnings via APIs
- Latest Release 2024-05-20
- EPS/Forecast NaN
Get Rasna Therapeutics Inc End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also: